23:34 , Jul 25, 2019 |  BC Extra  |  Financial News

July 25 Financial Quick Takes: Livongo, Castle pop after IPOs; plus a K2HV-Evelo deal, earnings beats for AZ & Roche, and more

Livongo, Castle rise in first trading day  Livongo Health inc. (NASDAQ:LVGO) and Castle Biosciences Inc. (NASDAQ:CSTL) each posted gains in their first day of trading Thursday after pricing upsized IPOs. Digital health play Livongo added...
23:19 , Jul 15, 2019 |  BC Extra  |  Financial News

July 15 Financial Quick Takes: RA raises $300M for new fund; plus Alphamab and Castle

RA launches $300M VC fund  RA Capital raised $300 million for its first close-ended venture fund, dubbed Nexus, which will invest in private companies backed by the firm's main fund, RA Capital Healthcare Fund L.P....
02:33 , Jul 13, 2019 |  BioCentury  |  Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

The performance of 1H19 IPOs point toward a continuation of a dual-class system where biotechs backed by deep-pocketed VCs and crossover investors can tap the public market at will and generate stronger after-market performance than...
01:04 , Jun 28, 2019 |  BC Extra  |  Financial News

June 27 Financial Quick Takes: Esperion gets $125M from Oberland in funding deal for cholesterol candidates; plus Woodford, PanTheryx and Castle

Esperion, Oberland strike funding deal ahead of bempedoic acid launch  Esperion Therapeutics Inc. (NASDAQ:ESPR) forged a funding agreement with Oberland Capital tied to revenues from the sale of products containing the biotech's cholesterol-lowering candidate bempedoic...
23:41 , Dec 12, 2017 |  BC Extra  |  Company News

Management tracks: Achaogen, Minerva

Antibacterial company Achaogen Inc. (NASDAQ:AKAO) said Kenneth Hillan will step down as CEO, effective Jan. 1. He will remain president and president of R&D. Blake Wise, who has served as president and COO, will become...
19:36 , May 19, 2017 |  BC Week In Review  |  Financial News

Castle Biosciences draws down $10M of new $20M credit facility

Molecular diagnostics company Castle Biosciences Inc. (Friendswood, Texas) drew down $10 million of a new $20 million credit facility it secured on May 9 from Oxford Finance and Silicon Valley Bank. The facility comprises a...
01:25 , May 10, 2016 |  BC Extra  |  Company News

Management tracks

Metabolic company Arena Pharmaceuticals Inc. (NASDQ:ARNA) named Amit Munshi CEO and interim principal financial officer. He was president and CEO at Epirus Biopharmaceuticals Inc. (NASDAQ:EPRS). Epirus named Scott Rocklage, a director, CEO and promoted Chief...
07:00 , Aug 10, 2015 |  BC Week In Review  |  Company News

Castle Biosciences, FedMed Inc., Multiplan Inc., Preferred Medical Claim Solutions LLC sales and marketing update

FedMed, Multiplan and Preferred Medical will cover Castle’s DecisionDx assays. The company said the three networks cover more than 120 million lives. The real-time PCR tests include DecisionDx-Melanoma to predict metastatic risk in melanoma patients...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Financial News

Castle Biosciences completes venture financing

Castle Biosciences Inc. , Friendswood, Texas   Business: Diagnostic   Date completed: 2015-07-27   Type: Venture financing   Raised: $11.7 million   Investors: Industry Ventures; HealthQuest Capital; Mountain Group Capital   Note: Castle raised $11.7...
07:00 , Apr 20, 2015 |  BC Week In Review  |  Financial News

Castle Biosciences financial update

Castle Biosciences Inc. , Friendswood, Texas   Business: Diagnostic   Date announced: 2015-04-14   Note: Castle Biosciences secured a $6 million credit facility from Silicon Valley Bank. The company declined to disclose whether it drew...